Ionic Capital Management’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Ionic Capital Management’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-348,234	Closed	-$36.7K	–	209
2023 Q4	$36.7K	Sell	348,234 -69,154	-17%	-$10.2K	0.01%	144
2023 Q3	$93.9K	Sell	417,388 -319,318	-43%	-$85.8K	0.02%	154
2023 Q2	$193K	Sell	736,706 -406,642	-36%	-$79.2K	0.06%	131
2023 Q1	$206K	Hold	1,143,348	–	–	0.06%	155
2022 Q4	$229K	Sell	1,143,348 -192,336	-14%	-$82.5K	0.05%	180
2022 Q3	$962K	Buy	1,335,684 +79,330	+6%	+$54.2K	0.13%	164
2022 Q2	$666K	Sell	1,256,354 -2,997	-0.2%	-$1.9K	0.08%	184
2022 Q1	$1.11M	Sell	1,259,351 -14,920	-1%	-$16.6K	0.13%	170
2021 Q4	$2.85M	Buy	1,274,271 +758,055	+147%	+$2.45M	0.36%	85
2021 Q3	$1.75M	Buy	+516,216	New	+$1.84M	0.22%	124

Other funds holding DNA.WS

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JRCM

Jones Road Capital Management New York $55.3M AUM 29.97% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ionic Capital Management's DNA.WS Position: Q1 2024 in Review

Ionic Capital Management sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q1 2024, closing a stake of 348,234 shares — an estimated $36.7K sold.

Ionic Capital Management first reported a position in DNA.WS in Q3 2021 and held it in 10 quarters. The position peaked at $2.85M in Q4 2021. 28 funds tracked by Wall St. Rank hold DNA.WS as of Q1 2024.

Ionic Capital Management reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q1 2024 after selling out during the quarter.
Ionic Capital Management sold 348,234 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q1 2024, an estimated $36.7K.
Ionic Capital Management first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 10 quarters.
Ionic Capital Management's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $2.85M in Q4 2021.
28 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q1 2024.

Based on Ionic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.